Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

5.43
Delayed Data
As of 2:05pm ET
 -0.02 / -0.37%
Today’s Change
3.88
Today|||52-Week Range
14.99
-13.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash2.0M2.8M25.0M13.4M
 
 
 
 
 
Short Term Investment Cash-3.8M42.2M-19.2M-11.6M
 
 
 
 
 
Cash & Short Term Investments2.0M44.2M54.0M46.0M
 
 
 
 
 
 
ReceivablesReceivables0.00199.6K0.00298.7K
 
 
 
 
InventoriesInventories0.00----0.00--
 
Current AssetsPrepaid Expenses----1.5M246.9K
 
 
 
Other Current Assets299.1K292.9K106.2K106.2K
 
 
 
 
 
Current Assets2.3M44.7M55.6M46.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--460.0K460.0K479.5K
 
 
 
 
Depreciation---76.7K-230.0K-383.8K
 
 
 
 
Other Assets2.7M0.000.000.00
 
 
Total Assets5.0M85.3M60.5M98.2M
 
 
 
 
 
 
LiabilitiesAccrued Expenses5.4M2.7M2.3M5.9M
 
 
 
 
 
Other Current Liabilities5.4M3.0M2.8M6.7M
 
 
 
 
 
Other Liabilities5.5M5.0M4.5M9.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt2.0M0.000.000.00
 
 
Other Liabilities30.4K0.000.0031.2K
 
 
 
Total Liabilities7.5M5.7M5.1M10.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-2.5M79.6M55.4M88.1M
 
 
 
 
 
Total Shareholder Equity-2.5M79.6M55.4M88.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding7.5M13.1M13.3M18.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.